|
US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
|
US5049578A
(en)
|
1990-03-09 |
1991-09-17 |
E. R. Squibb & Sons, Inc. |
1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones
|
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
|
DE69818675T2
(de)
|
1997-07-29 |
2004-07-29 |
Alcon Laboratories, Inc., Fort Worth |
Galaktomannanpolymere und borat enthaltende augenarzneimittel
|
|
AU2483599A
(en)
|
1998-01-29 |
1999-08-16 |
Sepracor, Inc. |
Pharmaceutical uses of optically pure (-)-bupropion
|
|
CA2331735A1
(en)
|
1998-05-08 |
1999-11-18 |
Smithkline Beecham P.L.C. |
Phenylurea and phenylthio urea derivatives
|
|
WO2000047576A1
(en)
|
1999-02-12 |
2000-08-17 |
Smithkline Beecham Plc |
Cinnamide derivatives as orexin-1 receptors antagonists
|
|
DE60015927T2
(de)
|
1999-02-12 |
2005-04-07 |
Smithkline Beecham P.L.C., Brentford |
Phenylharnstoff und phenylthioharnstoffderivate
|
|
DE60013250T2
(de)
|
1999-02-12 |
2005-09-08 |
Smithkline Beecham P.L.C., Brentford |
Phenylharnstoff- und Phenylthioharnstoffderivate als Orexinrezeptorantagonisten
|
|
WO2000071511A2
(en)
|
1999-05-24 |
2000-11-30 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
WO2001085693A1
(en)
|
2000-05-11 |
2001-11-15 |
Banyu Pharmaceutical Co., Ltd. |
N-acyltetrahydroisoquinoline derivatives
|
|
EP1289955B1
(en)
|
2000-06-16 |
2005-04-13 |
Smithkline Beecham Plc |
Piperidines for use as orexin receptor antagonists
|
|
EP1353918B1
(en)
|
2000-11-28 |
2005-01-12 |
Smithkline Beecham Plc |
Morpholine derivatives as antagonists of orexin receptors
|
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
|
BR0209334A
(pt)
|
2001-05-05 |
2004-06-15 |
Smithkline Beecham Plc |
Aminas n-aroil cìclicas
|
|
US20040192673A1
(en)
|
2001-05-05 |
2004-09-30 |
Pascale Gaillard |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
|
GB0115862D0
(en)
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
|
GB0127145D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Compounds
|
|
GB0130335D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
|
GB0130393D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
|
GB0130341D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
|
JP4498922B2
(ja)
|
2002-07-09 |
2010-07-07 |
アクテリオン ファーマシューティカルズ リミテッド |
7,8,9,10−テトラヒドロ−6H−アゼピノ、6,7,8,9−テトラヒドロ−ピリドおよび2,3−ジヒドロ−2H−ピロロ[2,1−b]−キナゾリノン誘導体
|
|
WO2004026866A1
(en)
|
2002-09-18 |
2004-04-01 |
Glaxo Group Limited |
N-aroyl cyclic amines as orexin receptor antagonists
|
|
NZ538749A
(en)
|
2002-10-11 |
2006-11-30 |
Actelion Pharmaceuticals Ltd |
Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
|
|
GB0225944D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0225938D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0225884D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2003299648A1
(en)
|
2002-12-12 |
2004-06-30 |
Janssen Pharmaceutica, N.V. |
Substituted 4-phenyl-(1,3)-dioxanes
|
|
RU2345985C2
(ru)
|
2003-03-26 |
2009-02-10 |
Актелион Фармасьютиклз Лтд. |
Производные тетрагидроизохинолилацетамида в качестве антагонистов орексинового рецептора
|
|
ATE383345T1
(de)
|
2003-04-28 |
2008-01-15 |
Actelion Pharmaceuticals Ltd |
Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
|
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
|
EP1654002B2
(en)
|
2003-08-07 |
2014-01-29 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
HUP0304101A3
(en)
|
2003-12-22 |
2008-10-28 |
Sanofi Aventis |
Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
|
RU2378257C2
(ru)
|
2004-03-01 |
2010-01-10 |
Актелион Фармасьютиклз Лтд |
Замещенные производные 1,2,3,4-тетрагидроизохинолина
|
|
WO2006067224A2
(en)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
|
|
CA2603766A1
(en)
|
2005-04-12 |
2006-10-19 |
Merck & Co., Inc. |
Amidopropoxyphenyl orexin receptor antagonists
|
|
JP2008541698A
(ja)
|
2005-05-03 |
2008-11-27 |
アンサンブル ディスカバリー コーポレイション |
核酸検出のためのターンオーバープローブおよびその使用
|
|
US20090118200A1
(en)
|
2005-05-23 |
2009-05-07 |
Bergman Jeffrey M |
Proline bis-amide orexin receptor antagonists
|
|
CA2617324A1
(en)
|
2005-08-04 |
2007-02-15 |
Merck & Co., Inc. |
Aminoethane sulfonamide orexin receptor antagonists
|
|
JP2009506061A
(ja)
|
2005-08-26 |
2009-02-12 |
メルク エンド カムパニー インコーポレーテッド |
ジアザスピロデカンオレキシン受容体拮抗薬
|
|
WO2007061763A2
(en)
|
2005-11-22 |
2007-05-31 |
Merck & Co., Inc. |
Indole orexin receptor antagonists
|
|
CN101009515A
(zh)
|
2006-01-24 |
2007-08-01 |
华为技术有限公司 |
通信终端设备管理方法及通信终端
|
|
TW200800020A
(en)
|
2006-01-26 |
2008-01-01 |
Basf Ag |
Methods to use 3-pyridyl derivatives as pesticides
|
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
FR2896799B1
(fr)
|
2006-02-02 |
2008-03-28 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
US20090105318A1
(en)
|
2006-03-29 |
2009-04-23 |
Coleman Paul J |
Amidoethylthioether Orexin Receptor Antagonists
|
|
JP2009533419A
(ja)
|
2006-04-11 |
2009-09-17 |
アクテリオン ファーマシューティカルズ リミテッド |
新規スルホンアミド化合物
|
|
DE602007012072D1
(de)
|
2006-04-26 |
2011-03-03 |
Actelion Pharmaceuticals Ltd |
Orantagonisten
|
|
WO2007143813A1
(en)
|
2006-06-16 |
2007-12-21 |
Husky Injection Molding Systems Ltd. |
Preventative maintenance update system
|
|
EP2049110B1
(en)
|
2006-07-14 |
2014-08-20 |
Merck Sharp & Dohme Corp. |
Bridged diazepan orexin receptor antagonists
|
|
SI2049529T1
(sl)
|
2006-07-14 |
2010-11-30 |
Merck Sharp & Dohme |
Substituiran diazepan oreksin receptor antagonist
|
|
EP2049526A2
(en)
|
2006-07-14 |
2009-04-22 |
Merck & Co., Inc. |
2-substituted proline bis-amide orexin receptor antagonists
|
|
CA2659299A1
(en)
|
2006-08-15 |
2008-02-21 |
Actelion Pharmaceuticals Ltd |
Azetidine compounds
|
|
ATE458740T1
(de)
|
2006-08-28 |
2010-03-15 |
Actelion Pharmaceuticals Ltd |
1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
|
|
CL2007002809A1
(es)
|
2006-09-29 |
2008-04-18 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de 3-aza biciclo [3.1.0]hexano; y su uso en el tratamiento de enfermedades tales como desordenes psicoticos y de ansiedad, desordenes del sueno, uso y abuso de sustancias psicoactivas, demencia y deterioro de funciones cognitivas
|
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
|
CN101568533A
(zh)
|
2006-12-01 |
2009-10-28 |
埃科特莱茵药品有限公司 |
3-异芳基(氨基或酰胺基)-1-(联苯或苯基噻唑基)羰基哌啶衍生物食欲素受体抑制剂
|
|
AU2007337659A1
(en)
|
2006-12-22 |
2008-07-03 |
Actelion Pharmaceuticals Ltd. |
5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
|
|
AR064561A1
(es)
|
2006-12-28 |
2009-04-08 |
Actelion Pharmaceuticals Ltd |
Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
|
|
WO2008087611A2
(en)
|
2007-01-19 |
2008-07-24 |
Actelion Pharmaceuticals Ltd |
Pyrrolidine- and piperidine- bis-amide derivatives
|
|
EP2131654A4
(en)
|
2007-03-02 |
2011-02-02 |
Merck Sharp & Dohme |
Bipyridine-carboxamide-orexin receptor Antagonist
|
|
EP2114867B1
(en)
|
2007-03-05 |
2012-12-12 |
F. Hoffmann-La Roche AG |
Aminoamides as orexin antagonists
|
|
AU2008225922B2
(en)
|
2007-03-15 |
2012-04-26 |
F. Hoffmann-La Roche Ag |
Malonamides as orexin antagonists
|
|
CL2008000836A1
(es)
|
2007-03-26 |
2008-11-07 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras.
|
|
CA2681163A1
(en)
|
2007-04-04 |
2008-10-16 |
F. Hoffmann-La Roche Ag |
Heterocycles as orexin antagonists
|
|
US20100222328A1
(en)
|
2007-05-14 |
2010-09-02 |
Hamed Aissaoui |
2-cyclopropyl-thiazole derivatives
|
|
WO2008143856A1
(en)
|
2007-05-18 |
2008-11-27 |
Merck & Co., Inc. |
Oxo bridged diazepan orexin receptor antagonists
|
|
HRP20120240T1
(hr)
|
2007-05-23 |
2012-04-30 |
Merck Sharp & Dohme Corp. |
Piridil piperidin antagonisti receptora za oreksin
|
|
US8030495B2
(en)
|
2007-05-23 |
2011-10-04 |
Coleman Paul J |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
|
US8106215B2
(en)
|
2007-07-03 |
2012-01-31 |
Actelion Pharmaceuticals Ltd. |
3-aza-bicyclo[3.3.0]octane compounds
|
|
KR20100046047A
(ko)
|
2007-07-27 |
2010-05-04 |
액테리온 파마슈티칼 리미티드 |
2-아자-비시클로[3.3.0]옥탄 유도체
|
|
EP2185512B1
(en)
|
2007-07-27 |
2010-12-29 |
Actelion Pharmaceuticals Ltd. |
Trans-3-aza-bicyclo[3.1.0]hexane derivatives
|
|
BRPI0814767A2
(pt)
|
2007-08-02 |
2015-03-03 |
Hoffmann La Roche |
Derivados de monoamida como antagonistas do receptor de orexina
|
|
CA2695621A1
(en)
|
2007-08-09 |
2009-02-12 |
Merck Sharp & Dohme Corp. |
Pyridine carboxamide orexin receptor antagonists
|
|
ES2560095T3
(es)
|
2007-08-10 |
2016-02-17 |
Cortex Pharmaceuticals, Inc. |
Amidas bicíclicas para mejorar las respuestas sinápticas glutamatérgicas
|
|
ES2400830T3
(es)
|
2007-08-15 |
2013-04-12 |
Actelion Pharmaceuticals Ltd. |
Derivados de 1,2-diamido-etileno como antagonistas de orexina
|
|
US8288411B2
(en)
|
2007-09-24 |
2012-10-16 |
Actelion Pharmaceuticals Ltd. |
Pyrrolidines and piperidines as orexin receptor antagonists
|
|
EP2214676B1
(en)
|
2007-10-29 |
2012-11-21 |
Merck Sharp & Dohme Corp. |
Substituted diazepan orexin receptor antagonists
|
|
US8084464B2
(en)
|
2007-12-18 |
2011-12-27 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
|
KR101204213B1
(ko)
|
2007-12-21 |
2012-11-26 |
에프. 호프만-라 로슈 아게 |
오렉신 수용체 길항제로서의 헤테로아릴 유도체
|
|
ATE511500T1
(de)
|
2008-01-21 |
2011-06-15 |
Hoffmann La Roche |
Sulfonamide als orexin-antagonisten
|
|
CN101918361B
(zh)
|
2008-02-12 |
2014-05-28 |
弗·哈夫曼-拉罗切有限公司 |
哌啶磺酰胺衍生物
|
|
AU2009215243A1
(en)
|
2008-02-21 |
2009-08-27 |
Actelion Pharmaceuticals Ltd. |
2-aza-bicyclo[2.2.1]heptane derivatives
|
|
GB0806536D0
(en)
|
2008-04-10 |
2008-05-14 |
Glaxo Group Ltd |
Novel compounds
|
|
CA2726102A1
(en)
|
2008-06-11 |
2009-12-17 |
Actelion Pharmaceuticals Ltd |
Tetrazole compounds as orexin receptor antagonists
|
|
EP2297102A1
(en)
|
2008-06-16 |
2011-03-23 |
F. Hoffmann-La Roche AG |
Heteroaromatic monoamides as orexinin receptor antagonists
|
|
KR20110036069A
(ko)
|
2008-06-25 |
2011-04-06 |
액테리온 파마슈티칼 리미티드 |
5,6,7,8-테트라히드로-이미다조[1,5-a]피라진 화합물
|
|
WO2010004507A1
(en)
|
2008-07-07 |
2010-01-14 |
Actelion Pharmaceuticals Ltd |
Thiazolidine compounds as orexin receptor antagonists
|
|
JP5301665B2
(ja)
|
2008-07-29 |
2013-09-25 |
エフ.ホフマン−ラ ロシュ アーゲー |
オレキシンアンタゴニストとしてのピロリジン−3−イルメチル−アミン
|
|
AR072899A1
(es)
|
2008-08-07 |
2010-09-29 |
Merck Sharp & Dohme |
Derivados de terpiridina-carboxamida antagonistas de receptores de orexina, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del insomnio y la obesidad.
|
|
EP2161266A1
(en)
|
2008-08-22 |
2010-03-10 |
EVOTEC Neurosciences GmbH |
Benzofuran derivatives as orexin receptor antagonists
|
|
WO2010038200A1
(en)
|
2008-10-01 |
2010-04-08 |
Actelion Pharmaceuticals Ltd |
Oxazolidine compounds as orexin receptor antagonists
|
|
RU2011119217A
(ru)
|
2008-10-14 |
2012-11-27 |
Актелион Фармасьютикалз Лтд |
Производные фенетиламида и их гетероциклические аналоги
|
|
WO2010048013A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted morpholine orexin receptor antagonists
|
|
AU2009307920A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,3-disubstituted piperidine orexin receptor antagonists
|
|
AU2009307915A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted piperidine orexin receptor antagonists
|
|
AU2009307918A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,4-disubstituted pyrrolidine orexin receptor antagonists
|
|
AU2009307921A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Disubstituted azepan orexin receptor antagonists
|
|
JP2012506374A
(ja)
|
2008-10-21 |
2012-03-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
2,5−二置換ピペリジンオレキシン受容体アンタゴニスト
|
|
EP2349267B1
(en)
|
2008-10-30 |
2014-06-25 |
Merck Sharp & Dohme Corp. |
Pyridazine carboxamide orexin receptor antagonists
|
|
MX2011004551A
(es)
|
2008-10-30 |
2011-05-25 |
Merck Sharp & Dohme |
Antagonistas del receptor de orexina de isonicotinamida.
|
|
EP2349262B1
(en)
|
2008-10-30 |
2014-06-25 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted phenyl carboxamide orexin receptor antagonists
|
|
EP2358712A1
(en)
|
2008-11-26 |
2011-08-24 |
Glaxo Group Limited |
Piperidine derivatives useful as orexin receptor antagonists
|
|
JP2012509912A
(ja)
|
2008-11-26 |
2012-04-26 |
グラクソ グループ リミテッド |
新規の化合物
|
|
WO2010060470A1
(en)
|
2008-11-26 |
2010-06-03 |
Glaxo Group Limited |
Piperidine derivatives useful as orexin receptor antagonists
|
|
KR20110091581A
(ko)
|
2008-12-02 |
2011-08-11 |
글락소 그룹 리미티드 |
N-{[1r,4s,6r-3-(2-피리디닐카르보닐)-3-아자비시클로[4.1.0]헵트-4-일]메틸}-2-헤테로아릴아민 유도체 및 그의 용도
|
|
CA2745433A1
(en)
|
2008-12-02 |
2010-06-10 |
Glaxo Group Ltd. |
N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
|
|
JP2010155827A
(ja)
|
2008-12-04 |
2010-07-15 |
Takeda Chem Ind Ltd |
スピロ環化合物
|
|
GB0823467D0
(en)
|
2008-12-23 |
2009-01-28 |
Glaxo Group Ltd |
Novel Compounds
|
|
AR077525A1
(es)
|
2009-01-30 |
2011-09-07 |
Novartis Ag |
4-aril-butan-1,3-diamidas y composiciones farmaceuticas
|
|
CN102459229A
(zh)
|
2009-04-24 |
2012-05-16 |
葛兰素集团有限公司 |
用作食欲肽拮抗剂的3-氮杂二环[4.1.0]庚烷
|
|
WO2011005636A1
(en)
|
2009-07-09 |
2011-01-13 |
Merck Sharp & Dohme Corp. |
Tetrahydronapthyridine orexin receptor antagonists
|
|
EP2275421A1
(en)
|
2009-07-15 |
2011-01-19 |
Rottapharm S.p.A. |
Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
|
|
WO2011016234A1
(en)
|
2009-08-04 |
2011-02-10 |
Raqualia Pharma Inc. |
Picolinamide derivatives as ttx-s blockers
|
|
US20120149711A1
(en)
|
2009-08-24 |
2012-06-14 |
Glaxo Group Limited |
Piperidine derivatives used as orexin antagonists
|
|
EP2470523A1
(en)
|
2009-08-24 |
2012-07-04 |
Glaxo Group Limited |
5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder
|
|
ME03452B
(me)
|
2009-10-23 |
2020-01-20 |
Janssen Pharmaceutica Nv |
Disupstituisani oktahi-dropirolo[3,4-c]piroli kao modulatori oreksin receptora
|
|
EP2491031B1
(en)
|
2009-10-23 |
2013-08-07 |
Janssen Pharmaceutica N.V. |
Fused heterocyclic compounds as orexin receptor modulators
|
|
EP2491034B1
(en)
|
2009-10-23 |
2013-12-18 |
Janssen Pharmaceutica, N.V. |
Fused heterocyclic compounds as orexin receptor modulators
|
|
EP2493299A4
(en)
|
2009-10-29 |
2013-04-17 |
Merck Sharp & Dohme |
TERTIARY AMIDOREXIN RECEPTOR ANTAGONISTS
|
|
US20120258957A1
(en)
|
2009-11-23 |
2012-10-11 |
Matilda Jane Bingham |
Heterocyclic derivatives
|
|
WO2011073316A1
(en)
|
2009-12-18 |
2011-06-23 |
Novartis Ag |
4-aryl-butane-1,3-diamides
|
|
US8530648B2
(en)
|
2009-12-21 |
2013-09-10 |
Novartis Ag |
Diaza-spiro[5.5]undecanes
|
|
ES2460915T3
(es)
|
2009-12-21 |
2014-05-16 |
Novartis Ag |
Piridinas fusionadas con heteroarilo disustituido
|
|
WO2011138266A1
(en)
|
2010-05-03 |
2011-11-10 |
Evotec Ag |
Indolizine and imidazopyridine derivatives as orexin receptor antagonists
|
|
WO2011138265A2
(en)
|
2010-05-03 |
2011-11-10 |
Evotec Ag |
Indole and indazole derivatives as orexin receptor antagonists
|
|
MX2013006715A
(es)
|
2010-12-17 |
2013-08-26 |
Taisho Pharmaceutical Co Ltd |
Derivado de pirazol.
|
|
US20120165339A1
(en)
|
2010-12-22 |
2012-06-28 |
Eisai R&D Management Co., Ltd. |
Cyclopropane derivatives
|
|
US20120165331A1
(en)
|
2010-12-22 |
2012-06-28 |
Sangamesh Badiger |
Di/tri-aza-spiro-C9-C11alkanes
|
|
WO2012085857A1
(en)
|
2010-12-22 |
2012-06-28 |
Actelion Pharmaceuticals Ltd |
3,8-diaza-bicyclo[4.2.0]oct-3-yl amides
|
|
WO2012089606A1
(en)
|
2010-12-28 |
2012-07-05 |
Glaxo Group Limited |
Azabicyclo [4.1.0] hept - 4 - yl derivatives as human orexin receptor antagonists
|
|
WO2012089607A1
(en)
|
2010-12-28 |
2012-07-05 |
Glaxo Group Limited |
Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors
|
|
ES2541531T3
(es)
|
2011-02-18 |
2015-07-21 |
Actelion Pharmaceuticals Ltd. |
Nuevos derivados de pirazol e imidazol útiles como antagonistas de orexina
|
|
WO2012114252A1
(en)
|
2011-02-21 |
2012-08-30 |
Actelion Pharmaceuticals Ltd |
Novel indole and pyrrolopyridine amides
|
|
WO2012145581A1
(en)
|
2011-04-20 |
2012-10-26 |
Janssen Pharmaceutica Nv |
Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
|
|
US20140081025A1
(en)
|
2011-05-10 |
2014-03-20 |
Taisho Pharmaceutical Co., Ltd. |
Heteroaromatic ring derivative
|
|
EP2730573A4
(en)
|
2011-07-05 |
2014-12-03 |
Taisho Pharmaceutical Co Ltd |
METHYLPIPERIDINDERIVAT
|
|
WO2013050938A1
(en)
|
2011-10-04 |
2013-04-11 |
Actelion Pharmaceuticals Ltd |
3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
|
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
|
WO2013059163A1
(en)
|
2011-10-21 |
2013-04-25 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted thiomorpholine orexin receptor antagonists
|
|
EP2771001A4
(en)
|
2011-10-25 |
2015-03-25 |
Merck Sharp & Dohme |
PIPERIDINYL-alkyne-orexin
|
|
US9242995B2
(en)
|
2011-10-25 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Isoxazolopyridine orexin receptor antagonists
|
|
SI2776430T1
(sl)
|
2011-11-08 |
2016-06-30 |
Actelion Pharmaceuticals Ltd. |
2-(1,2,3-triazol-2-il)benzamidni in 3-(1,2,3-triazol-2-il)pikolinamidni derivati kot antagonisti oreksinskega receptorja
|
|
ITMI20112329A1
(it)
|
2011-12-21 |
2013-06-22 |
Rottapharm Spa |
Nuovi derivati spiro amminici
|
|
US9440982B2
(en)
|
2012-02-07 |
2016-09-13 |
Eolas Therapeutics, Inc. |
Substituted prolines/piperidines as orexin receptor antagonists
|
|
JP6346862B2
(ja)
|
2012-02-07 |
2018-06-20 |
エオラス セラピューティクス, インコーポレイテッド |
オレキシンレセプターアンタゴニストとしての置換プロリン/ピペリジン
|
|
US9416109B2
(en)
|
2012-02-17 |
2016-08-16 |
Eisai R&D Management Co., Ltd. |
Methods and compounds useful in the synthesis of orexin-2 receptor antagonists
|
|
ITMI20120322A1
(it)
*
|
2012-03-01 |
2013-09-02 |
Rottapharm Spa |
Composti di 4,4-difluoro piperidina
|
|
ITMI20120424A1
(it)
|
2012-03-19 |
2013-09-20 |
Rottapharm Spa |
Composti chimici
|
|
TW201613891A
(en)
|
2014-02-12 |
2016-04-16 |
Eolas Therapeutics Inc |
Substituted prolines / piperidines as orexin receptor antagonists
|